- Article
Galectin-3 (Gal-3) Inhibitors as Radiosensitizers for Prostate Cancer
- Renato M. Rodrigues,
- Bárbara Matos,
- Vera Miranda-Gonçalves,
- Carmen Jerónimo and
- Margarida Fardilha
Introduction: Radioresistance in prostate cancer (PCa) poses a major therapeutic challenge. Galectin-3 (Gal-3) is overexpressed in aggressive PCa and may contribute to resistance mechanisms. This study evaluated the role of Gal-3 in radioresistance a...

